At a glance
ClinicalIndex Comparison RecordN/ACompleted· 675 enrolled
Drug / intervention
LID015385 soft contact lenses +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Safety and Effectiveness Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens
In Brief
A clinical study evaluating LID015385 soft contact lenses and Comfilcon A soft contact lenses for Refractive Ametropia. Completed, enrolled 675 participants across 42 sites.
Detailed Summary
The purpose of this clinical trial is to evaluate the safety and performance of an investigational soft contact lens compared to a commercially available soft contact lens when worn in an extended wear modality.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRefractive Ametropia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedSep 2019
Enrollment StartOct 2019
Primary CompletionMar 2021
TodayJul 2026
First PostedSep 11, 2019
Enrollment StartOct 11, 2019
Primary CompletionMar 26, 2021
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 6.8 years ago
Interventions
LID015385 soft contact lensesdevice
Investigational silicone hydrogel contact lenses for up to 6 nights/7 days of continuous wear
Comfilcon A soft contact lensesdevice
Silicone hydrogel contact lenses for up to 6 nights/7 days of continuous wear